Company data
Emergent BioSolutions Inc. employees and revenue per employee
EBS · Drug Manufacturers - Specialty & Generic · $364M market cap
Emergent BioSolutions Inc. had 900 employees at the end of fiscal Dec 2025, unchanged from a year earlier. Revenue for the year was $743M, down 28.8% from a year earlier, or $825K per employee. Revenue fell, and headcount fell or held flat with it.
Employees
900
+0.0% YoY
Revenue
$743M
-28.8% YoY
Revenue / employee
$825K
Peer median $825K
Rank in industry
9 of 17
Drug Manufacturers - Specialty & Generic
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 900 | $743M | $825K | +0.0% | -28.8% |
| Dec 2024 | 900 | $1.04B | $1.16M | -43.8% | -0.5% |
| Dec 2023 | 1,600 | $1.05B | $656K | -36.0% | -6.1% |
| Dec 2022 | 2,500 | $1.12B | $447K | +3.5% | -37.0% |
| Dec 2021 | 2,416 | $1.77B | $734K | +9.8% | +12.4% |
| Dec 2020 | 2,200 | $1.58B | $717K | +20.0% | +42.6% |
| Dec 2019 | 1,834 | $1.11B | $603K | +7.6% | +41.4% |
| Dec 2018 | 1,705 | $782M | $459K | +35.7% | +39.5% |
| Dec 2017 | 1,256 | $561M | $447K | +14.4% | +14.8% |
| Dec 2016 | 1,098 | $489M | $445K | — | — |
Open roles: we have not matched a verified job board for this company yet.
Emergent BioSolutions Inc. against similar companies
The closest industry peers by revenue, from Drug Manufacturers - Specialty & Generic.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| COLL Collegium Pharmaceutical, Inc. | 423 | $781M | $1.85M | Efficient growth |
| INDV Indivior Pharmaceuticals Inc | 827 | $1.24B | $1.50M | Leaner |
| LNTH Lantheus Holdings, Inc. | 1,193 | $1.54B | $1.29M | Hiring ahead |
| SUPN Supernus Pharmaceuticals, Inc. | 778 | $719M | $924K | Hiring ahead |
| ANIP ANI Pharmaceuticals, Inc. | 970 | $883M | $911K | Efficient growth |
| PCRX Pacira BioSciences, Inc. | 825 | $726M | $880K | Hiring ahead |
| EBS Emergent BioSolutions Inc. | 900 | $743M | $825K | Contracting |
| PAHC Phibro Animal Health Corporation | 2,605 | $1.52B | $583K | Efficient growth |
| AMPH Amphastar Pharmaceuticals, Inc. | 1,976 | $720M | $364K | Contracting |
Questions about Emergent BioSolutions Inc.
- How many employees does Emergent BioSolutions Inc. have?
- Emergent BioSolutions Inc. reported 900 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 27, 2026. That is unchanged from a year earlier.
- What is Emergent BioSolutions Inc.'s revenue per employee?
- Emergent BioSolutions Inc. brought in $743M of revenue in fiscal Dec 2025, which is $825K per employee. That ranks 9 of 17 companies we track in Drug Manufacturers - Specialty & Generic, where the median is $825K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare EBS with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Emergent BioSolutions Inc.'s annual reports (Form 10-K), latest filed February 27, 2026. This is data, not a recommendation to buy or sell EBS.